TCIIS
REGN icon

TIAA-CREF Individual & Institutional Services’s Regeneron Pharmaceuticals REGN Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$965K Buy
1,548
+238
+18% +$162K ﹤0.01% 364
2026
Q1 		$1.01M Buy
+1,310
New +$1M ﹤0.01% 339

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's REGN Position: Q2 2026 in Review

TIAA-CREF Individual & Institutional Services increased its Regeneron Pharmaceuticals (REGN) stake by 18% in Q2 2026, buying an estimated $162K and bringing the position to 1,548 shares worth $965K. The position accounts for ﹤0.01% of the portfolio, ranked #364.

TIAA-CREF Individual & Institutional Services first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.01M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • TIAA-CREF Individual & Institutional Services held 1,548 shares of Regeneron Pharmaceuticals worth $965K as of Q2 2026.
  • TIAA-CREF Individual & Institutional Services bought 238 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $162K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q2 2026, its #364 holding.
  • TIAA-CREF Individual & Institutional Services first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • TIAA-CREF Individual & Institutional Services's Regeneron Pharmaceuticals position peaked at $1.01M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q2 2026, filed 10 Aug 2026.